MEDICAMENTE ONCOLOGIE
Buyer: Spitalul Clinic C.F. nr. 2 Bucuresti
- Published
- 18 September 2025
- Place of performance
- RO321
- Procedure
- Open procedure
- Notice number
- 00609065-2025
- Reference
- b40b7d12-e068-4aa4-835f-109080c72421
- Official source
- Official source
CPV codes
- 33652100Agentes antineoplásicos
Description
Autoritatea contractantă intenționează să achiziționeze, pentru buna functionare a activitatii spitalicesti o gama variata de : “ MEDICAMENTE ONCOLOGIE” in cantitatile si cu specificatiile tehnice prevazute in caietul de sarcini . Cantitatile minime si maxime acord cadru si contracte subsecvente conform caietului de sarcini. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor :19 . Autoritatea contractanta va rapunde in mod clar si complet tuturor solicitarilor de clarificari: in a 11-a zi inainte de termenul limita stabilit pentru depunerea ofertelor.
Lots (58)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Atezolizumab 1200mg/20ml | 33652100 Agentes antineoplásicos | — |
| 2 | Atezolizumab fl15ml/1875mg | 33652100 Agentes antineoplásicos | — |
| 3 | Avelumabum f 200mg/10ml | 33652100 Agentes antineoplásicos | — |
| 4 | Bendamustina fl.2.5mg/ml*10ml (25mg) | 33652100 Agentes antineoplásicos | — |
| 5 | Bendamustina fl 2,5mg/50 ml(.100mg) | 33652100 Agentes antineoplásicos | — |
| 6 | Bortezomib pulb 3,5 mg/10ml | 33652100 Agentes antineoplásicos | — |
| 7 | Bleomycinum sulfas 15000 ui- pulb sol inj | 33652100 Agentes antineoplásicos | — |
| 8 | Cabazitaxel fl.45mg/4.5ml (10mg/ml) | 33652100 Agentes antineoplásicos | — |
| 9 | Cabazitaxel fl.60 mg / 20 mg/ml x 3 ml | 33652100 Agentes antineoplásicos | — |
| 10 | Carboplatinum 10 mg/ml x 5ml | 33652100 Agentes antineoplásicos | — |
| 11 | Carboplatinum 10 mg/ml x 60 ml | 33652100 Agentes antineoplásicos | — |
| 12 | Calcii folinas fl.10mg/ml*35ml | 33652100 Agentes antineoplásicos | — |
| 13 | Calcii folinas fl.10mg/ml*10ml | 33652100 Agentes antineoplásicos | — |
| 14 | Carfilzomibum fl.60mg x 1 fl x 50 ml | 33652100 Agentes antineoplásicos | — |
| 15 | Ciclofosfamida 500 mg/ml conc.pt.sol.inj/perf. | 33652100 Agentes antineoplásicos | — |
| 16 | Ciclofosfamida 1000 mg/2ml conc.pt.sol.inj/perf. | 33652100 Agentes antineoplásicos | — |
| 17 | Ciclofosfamida 2000 mg/4ml conc.pt.sol.inj/perf. | 33652100 Agentes antineoplásicos | — |
| 18 | Cisplatinum fl.10ml , 1 mg/ml | 33652100 Agentes antineoplásicos | — |
| 19 | Cisplatinum fl.25ml | 33652100 Agentes antineoplásicos | — |
| 20 | Cisplatinum 100ml, 1 mg/ml | 33652100 Agentes antineoplásicos | — |
| 21 | Cyitarabinum fl.20mg/ml*5ml | 33652100 Agentes antineoplásicos | — |
| 22 | Cyitarabinum fl.10 ml, 100 mg/ml | 33652100 Agentes antineoplásicos | — |
| 23 | Cytarabinum - fl.20ml, 100 mg/ml | 33652100 Agentes antineoplásicos | — |
| 24 | Daratumumab 120mg/ml*15ml (1800mg) | 33652100 Agentes antineoplásicos | — |
| 25 | Docetaxelum 6 ml/120mg | 33652100 Agentes antineoplásicos | — |
| 26 | Doxorubicinum 2mg/ml*5ml (10mg) | 33652100 Agentes antineoplásicos | — |
| 27 | Doxorubicinum 2mg/ml*10ml (20mg) | 33652100 Agentes antineoplásicos | — |
| 28 | Doxorubicinum 2mg/ml*25ml | 33652100 Agentes antineoplásicos | — |
| 29 | Doxorubicinum 2mg/ml*50ml | 33652100 Agentes antineoplásicos | — |
| 30 | Doxorubicinum 2mg/ml*100ml | 33652100 Agentes antineoplásicos | — |
Award criteria
- Price — Pretul cel mai scazut este singurul criteriu
Awards
| Awarded to | Amount | Date |
|---|---|---|
| FARMEXIM S.A. | 12,153,600 RON | — |
| BIO EEL S.R.L. | 12,150,000 RON | — |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 12,137,325 RON | — |
| DR.MAX | 9,473,240 RON | — |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 9,436,392 RON | — |
| FARMEXIM S.A. | 9,378,112 RON | — |
| DR.MAX | 6,356,076 RON | — |
| FARMEXIM S.A. | 6,355,744 RON | — |
| FARMEXIM S.A. | 6,355,744 RON | — |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 6,354,780 RON | — |
Official publications
- TED · 00609065-2025 · 18 September 2025
- OJS · 179/2025 · 18 September 2025
Other tenders from Spitalul Clinic C.F. nr. 2 Bucuresti
- “ MEDICAMENTE UZ UMAN”
- Reactivi compatibili cu aparatul integrat de biochimie si imunologie Cobas pro c 503 & e 801
- Reactivi compatibili cu aparatul integrat de biochimie si imunologie Cobas pro c 503 & e 801
- “ MEDICAMENTE UZ UMAN”
- acord-cadru privind furnizarea de echipamente și dispozitive medicale necesare dotării Spitalul Clinic CF2 București -Loturile 1,2,3,4,5"
- MEDICAMENTE ONCOLOGIE
- Reactivi compatibili cu aparatul integrat de biochimie si imunologie Cobas pro c 503 & e 801
- MEDICAMENTE ONCOLOGIE
- Reactivi compatibili cu aparatul integrat de biochimie si imunologie Cobas pro c 503 & e 801
- Achiziția unei solutii software integrate si interoperabile cu aplicabilitate clinica si non clinica si produse hardware si software în…
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Spitalul Clinic C.F. nr. 2 Bucuresti (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.